The PV market is growing due to increasing disease awareness and novel therapeutic developments. Key players including PharmaEssentia (Besremi), Incyte Corporation (Jakafi), and Protagonist Therapeutics are advancing JAK inhibitors and targeted therapies that improve symptom management and reduce thrombotic risk. Diagnostic advancements and treatment guidelines are further optimizing patient care strategies. Access Full Report: https://www.delveinsight.com/infographics/polycythemia-vera-market?utm_source=infographics&utm_medium=promotion&utm_campaign=kkpr